About S2Medical AB 
S2Medical AB
Pharmaceuticals & Biotechnology
S2Medical AB (publ) is a Sweden-based medical technology company. The Company focuses on developing products for healing burns and chronic wounds, from debridement and granulation to reepithelialization. The Company's product portfolio includes INSTAQRETT, a sterile single-use mechanical debridement tool, the Epiprotect product line based on its collagen-mimicking Eiratex material, which includes EPIPROTECT Safestop, a blood-stilling membrane dressing, EPIPROTECT 2117, a synthetic substitute to allografts and xenografts, EPIPROTECT ULCER, dressing for treating ulcers, as well as INSTABIND bandages and Instagraft, a single-use medical device designed to treat chronic wounds with microtransplants from the patient's own skin without creating any new wounds. The Company is also the official distributor of Silverlon antimicrobial dressings for Nordic countries. In addition, it operates the S2Clinic, a wound healing center in Sweden.
Company Coordinates 
Company Details
Sunnorpsgatan 5 , LINKOPING None : 582 73
Registrar Details
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Management
Designation
Mr. Amin Omrani
Independent Chairman of the Board
Mr. Marten Skog
Chief Operating Officer, Director
Mr. Martin Zetterstrom
Director
Mr. Carsten Browall
Independent Director
Mr. Roland Frosing
Independent Director
Revenue and Profits:
Net Sales:
8 Million
(Quarterly Results - Dec 2024)
Net Profit:
-2 Million
Pharmaceuticals & Biotechnology
SEK 9 Million ()
7.00
NA
0.00%
-0.07
8.02%
0.47






